Telehealth Intervention for Financial Hardship in Caregivers
Trial Summary
What is the purpose of this trial?
This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general belief in the ability to cope with daily life. Caregivers of patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC) demonstrate that they endure high depressive symptom burdens and financial distress. Further, they experience symptom trajectories that differ from those of patients. In short, they require differential timing of supportive interventions. This study aims to reduce financial toxicity and distress levels and to increase self-efficacy, satisfaction and engagement with care. Information gathered from this study may help researchers determine whether telehealth interventions for caregivers may increase awareness of recommended resources that could be beneficial during caregivers journey.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Telehealth Intervention, Telehealth Therapy, Virtual Behavioral Intervention, Online ADHD Support for financial hardship in caregivers?
Research shows that telehealth interventions can effectively improve mental health for caregivers, with significant improvements in depression, anxiety, and stress. Additionally, telehealth models for ADHD treatment have shown greater improvements in caregiver distress and empowerment compared to traditional care.12345
Is telehealth intervention safe for caregivers?
How is the Telehealth Intervention treatment unique for addressing financial hardship in caregivers?
The Telehealth Intervention is unique because it uses technology like video calls and online platforms to provide support and therapy remotely, making it more accessible for caregivers who may face barriers to in-person services. This approach can improve mental health and reduce stress for caregivers, offering a flexible and convenient alternative to traditional face-to-face therapy.13489
Research Team
Eligibility Criteria
This trial is for primary caregivers of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC). It aims to help those experiencing high levels of depression and financial stress due to their caregiving responsibilities.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive telehealth navigation intervention which may consist of referral to specific resources for caregiving experience
Follow-up
Participants are monitored for outcomes such as financial distress, depression, and quality of life
Treatment Details
Interventions
- Telehealth Intervention (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Dr. L. Ebony Boulware
Wake Forest University Health Sciences
Chief Medical Officer since 2022
MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health
Dr. Julie Ann Freischlag
Wake Forest University Health Sciences
Chief Executive Officer since 2020
BS from University of Illinois, MD from Rush University
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School